Overview of Viatris PharmaceuticalsViatris is a global healthcare company that was formed in November 2020 through a merger between Mylan and Upjohn, a division of Pfizer. The company's headquarters i...
Viatris Pharmaceuticals is a company that produces EpiPen 2-Pak auto-injectors, which are used to administer epinephrine in emergency situations like anaphylaxis. EpiPen 2-Pak cartons include two EpiPen auto-injectors that should be carried around at all times by people who are at risk of severe allergic reactions. The company offers savings programs and a patient assistance program to help eligible patients reduce the out-of-pocket costs of their EpiPen 2-Pak purchases. The EpiPen 2-Pak is also available for free through the EpiPen4Schools program, which provides schools with free EpiPen auto-injectors in case of an emergency.
In addition, Viatris Pharmaceuticals settled a major antitrust lawsuit in February 2022 related to the pricing of EpiPens, which involved allegations of price gouging and anti-competitive practices. As a result, the company agreed to pay $264 million to settle the lawsuit.
Overall, Viatris Pharmaceuticals plays an important role in providing access to life-saving medication like the EpiPen 2-Pak. The company offers various programs and initiatives to help patients and schools in need, while also being held accountable for meeting ethical and legal standards in the pharmaceutical industry.